Terlipressin Clinical Trials

3 actively recruiting trials

Also known as: carbitocin, glypressin

Pipeline

Phase 2: 1

Top Sponsors

Wael Elbanna Clinic2
Noorik Biopharmaceuticals AG1

Indications

Myoma2
Cancer2
Hepatorenal Syndrome1
Ascites Hepatic1
Liver Disease1

Other3 trials

Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome

Phase 2

The Effect of Intracapsular Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Laparoscopic Myomectomy Operations

N/A

The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Without Using Haemostatic Tourniquets

N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.